Signe Schmidt
Overview
Explore the profile of Signe Schmidt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
67
Citations
443
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McCarthy O, Christensen M, Tawfik S, Kristensen K, Hartmann B, Holst J, et al.
Nutrients
. 2024 Dec;
16(23.
PMID: 39683492
Objectives: This article compares metabolic, pancreatic, and gut-derived hormone responses to isomaltulose ingestion, before versus during submaximal sustained exercise, in adults with type 1 diabetes (T1D) using automated insulin delivery...
2.
Shah V, Peters A, Umpierrez G, Sherr J, Akturk H, Aleppo G, et al.
J Diabetes Sci Technol
. 2024 Nov;
19(1):191-216.
PMID: 39517127
With increasing prevalence of obesity and cardiovascular diseases, there is a growing interest in the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) as an adjunct therapy in type 1 diabetes...
3.
Holmager P, Christensen M, Norgaard K, Schmidt S
J Diabetes Sci Technol
. 2024 Oct;
19(2):286-291.
PMID: 39417493
Introduction: Automated insulin delivery (AID) systems have improved glycemic control in individuals with type 1 diabetes (T1D) but overweight and increased cardiovascular risk remain a challenge. Glucagon-like peptide-1 receptor agonists...
4.
Klonoff D, Freckmann G, Pleus S, Kovatchev B, Kerr D, Tse C, et al.
J Diabetes Sci Technol
. 2024 Oct;
18(6):1346-1361.
PMID: 39369312
Introduction: An error grid compares measured versus reference glucose concentrations to assign clinical risk values to observed errors. Widely used error grids for blood glucose monitors (BGMs) have limited value...
5.
Kjeldsen S, Richter M, Jensen N, Nilsson M, Heinz N, Nybing J, et al.
Diabetes
. 2024 Jul;
73(10):1716-1727.
PMID: 38976454
Article Highlights:
6.
Richter M, Kemp I, Heeboll S, Winther-Sorensen M, Kjeldsen S, Jensen N, et al.
Metabolism
. 2024 Apr;
156:155915.
PMID: 38631460
Introduction: Glucagon receptor agonism is currently explored for the treatment of obesity and metabolic dysfunction-associated steatotic liver disease (MASLD). The metabolic effects of glucagon receptor agonism may in part be...
7.
Christensen M, Ranjan A, Rytter K, McCarthy O, Schmidt S, Norgaard K
J Diabetes Sci Technol
. 2024 Apr;
:19322968241242399.
PMID: 38600822
Background: Automated insulin delivery (AID) systems offer promise in improving glycemic outcomes for individuals with type 1 diabetes. However, data on those who struggle with suboptimal glycemic levels despite insulin...
8.
Lorenzen J, Madsen K, Cleal B, Joensen L, Norgaard K, Pedersen-Bjergaard U, et al.
BMJ Open
. 2024 Mar;
14(3):e080053.
PMID: 38531585
Introduction: The study aimed to investigate independent and combined associations between insulin delivery method (insulin pump therapy (IPT) vs multiple daily injections (MDI)), glucose monitoring method (intermittently scanned continuous glucose...
9.
Tian T, Aaron R, DuNova A, Jendle J, Kerr D, Cengiz E, et al.
J Diabetes Sci Technol
. 2024 Mar;
18(5):1208-1244.
PMID: 38528741
Diabetes Technology Society hosted its annual Diabetes Technology Meeting from November 1 to November 4, 2023. Meeting topics included digital health; metrics of glycemia; the integration of glucose and insulin...
10.